Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sarepta-Glaxo Duchenne's Rivalry Heats Up This Week
TheStreet.com
Monday, April 8, 2013 - 11:27am
tags:
GSK, Sarepta, Duchenne Muscular Dystrophy, drisapersen, Prosensa, eteplirsen
What You Need To Know About Keryx And Zerenex's IP
Seeking Alpha
Monday, April 8, 2013 - 11:25am
tags:
Keryx, Zerenex
Bristol-Myers New R&D Chief Plans to Keep Focus on Cancer
Bloomberg
Monday, April 8, 2013 - 11:24am
tags:
R&D, cancer, Bristol-Myers Squibb
Pharmacyclics says FDA grants Breakthrough Therapy Designation for ibrutinib
Yahoo/Fly on the Wall
Monday, April 8, 2013 - 11:05am
tags:
FDA, Pharmacyclics, ibrutinib, CLL
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Monday, April 8, 2013 - 11:03am
tags:
immuno-oncology, cancer, Bristol-Myers Squibb, AbbVie, Ariad Pharmaceuticals, JNJ, Eli Lilly, Novartis, Pfizer, Medivation, Erbitux, Yervoy, Sprycel, Orencia
Why Pacira Pharmaceuticals May Be About to Take Off
Motley Fool
Monday, April 8, 2013 - 11:01am
tags:
Pacira
Merck Starts Fresh Trial on Fosamax Broken-Leg Claims
Bloomberg
Monday, April 8, 2013 - 11:00am
tags:
Fosamax, osteoporosis
Merck & Co: Growth Will Become Stagnant
Seeking Alpha
Monday, April 8, 2013 - 10:59am
tags:
Merck
Oramed Pharma's core technology in oral delivery of proteins gets Japanese patent
Pharmabiz
Sunday, April 7, 2013 - 11:04am
tags:
Oramed Pharmaceuticals
China Biotech In Review: Sanofi In The Hunt For China M&A
Seeking Alpha
Sunday, April 7, 2013 - 11:00am
tags:
Jiangsu Hengrui Medicine, Sanofi, Hangzhou Nurotron Biotechnology
Final Four Stocks: Celgene vs. Johnson & Johnson
Motley Fool
Sunday, April 7, 2013 - 10:57am
tags:
Celgene, JNJ
3 Things Buffett Likes About Health Care
Motley Fool
Sunday, April 7, 2013 - 10:55am
tags:
Warren Buffett
This Week in Biotech
Motley Fool
Sunday, April 7, 2013 - 10:55am
tags:
JNJ, Optimer, Biogen, Merck, Cubist Pharmaceuticals, AstraZeneca, Rigel Pharmaceuticals, AbbVie, Pfizer
3 Biotechs With Recent Intensive Insider Buying
Seeking Alpha
Sunday, April 7, 2013 - 10:52am
tags:
Tetraphase Pharmaceuticals, Enanta, Inovio
How to Play the Immediate Uncertainty of this Promising Biotech Stock
Motley Fool
Sunday, April 7, 2013 - 10:45am
tags:
Sarepta Therapeutics
Amgen: Long-Term Buy After A Pull Back
Seeking Alpha
Sunday, April 7, 2013 - 10:44am
tags:
Amgen
This Biotech Stock Looks Like a Good Investment
Motley Fool
Sunday, April 7, 2013 - 10:44am
tags:
Immunogen
Why Acadia Pharmaceuticals Remains A Strong Buy
Seeking Alpha
Sunday, April 7, 2013 - 10:43am
tags:
Acadia
Should You Bet on These Hot Healthcare Stocks?
Motley Fool
Sunday, April 7, 2013 - 10:42am
tags:
Gilead Sciences, Cadence Pharmaceuticals, United Health
How Doctors Actually Diagnose Obesity
Motley Fool
Sunday, April 7, 2013 - 10:41am
tags:
obesity, weight loss, Vivus, Arena Pharmaceuticals, Orexigen, Belviq, Qsymia, Contrave

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.